CellSearch

Raritan, United States Founded: 2012 • Age: 14 yrs Acquired By Silicon Biosystems
Circulating tumor cells are detected via specialized blood tests.

About CellSearch

CellSearch is a Healthcare company based in Raritan (United States) founded in 2012, and was acquired by Silicon Biosystems in December 2016. Circulating tumor cells are detected via specialized blood tests. The company has 67 employees. CellSearch has completed 1 acquisition, including Immunicon. Its focus areas include Life Sciences, Oncology, In-Vitro Diagnostic Tests and Diversified. Its legal entity is MENARINI SILICON BIOSYSTEMS, INC. Its competitors include Guardant Health, Foundation Medicine and ArcherDX; 3 of its 3 listed competitors have raised funding.

Company details

Founded in 2012 and based in Raritan, United States, operations focus on the healthcare sector, specifically oncology diagnostics. Blood tests are provided through the CellSearch System, which utilizes immunomagnetic capture and fluorescence imaging to identify circulating tumor cells of epithelial origin. This technology is applied to assess prognosis and survival outcomes for patients with metastatic breast, colorectal, or prostate cancer during treatment monitoring.

  • Headquarters Raritan, United States
  • Employees 67
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Website cellsearchctc.com
  • Social LinkedIn
  • Acquired by Silicon Biosystems (Dec 2016)
  • Legal Name Menarini Silicon Biosystems, Inc.
Key Metrics

Investors in CellSearch

CellSearch has secured backing from 1 investor. Prominent investors backing the company include Silicon Biosystems.

All
InvestorDescriptionFounded YearDomainLocation
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
1999siliconbiosystems.comBologna, Italy
Premium access

Investor details for CellSearch

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Investments & Acquisitions by CellSearch

CellSearch has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Immunicon.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Cell and molecular-based diagnostics for cancer management are developed.
immunicon.comBryn Athyn, United States1983Jun 2008$31M
Premium access

Complete acquisition details for CellSearch

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of CellSearch

3 dated milestones of CellSearch across 8 years, from founding to its latest funding, stage changes and deals.

  1. Acquisition Acquires Immunicon.
  2. Founded CellSearch is founded.
  3. Exit Acquired by Silicon Biosystems.

Competitors of CellSearch

CellSearch has 3 listed competitors in our database, 3 of them funded. They include Guardant Health, Foundation Medicine and ArcherDX.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
guardanthealth.com2012Redwood, United States$557.5M1,351
Digital sequencing technology for cancer detection is developed.
foundationmedicine.com2010Cambridge, United States$96.5M1,707
Genomics-based diagnostic tests for cancer are provided.
archerdx.com2013Boulder, United States$152.6M429
Molecular cancer diagnostic products are developed using patented AMP technology.
Premium access

Detailed competitors of CellSearch

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of CellSearch

The website of CellSearch (cellsearchctc.com) receives about 2.2K visits a month.

  • Monthly visits
    2.2K

    ▼ 5.9% vs previous month

Similar websites

Websites whose visitors overlap most with CellSearch. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
dkfz.de
100%
238.2K#124,343View details
nature.com
80%
33.6M#1,922View details
hayadan.org.il
hayadan.org.il
60%
#228,273–
cellsearchruo.com
cellsearchruo.com
39%
–

Top companies in Genomics & Gene Therapy Platforms

3 companies that operate in the same segment as CellSearch (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M4,867
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 2 BUSD 147.17 M1,141
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Cellsearch

Premium access

Complete news archive for CellSearch

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about CellSearch

CellSearch was founded in 2012.

CellSearch is headquartered in Raritan, United States. It is registered at Raritan, New Jersey, United States.

CellSearch has 67 employees.

Founded in 2012 and based in Raritan, United States, operations focus on the healthcare sector, specifically oncology diagnostics. Blood tests are provided through the CellSearch System, which utilizes immunomagnetic capture and fluorescence imaging to identify circulating tumor cells of epithelial origin. This technology is applied to assess prognosis and survival outcomes for patients with metastatic breast, colorectal, or prostate cancer during treatment monitoring.

CellSearch's top competitors include Guardant Health, Foundation Medicine and ArcherDX.

CellSearch has made 1 acquisition, including Immunicon.

CellSearch has 1 investor. Key investors include Silicon Biosystems.

CellSearch operates through Menarini Silicon Biosystems, Inc..

Yes. CellSearch was acquired by Silicon Biosystems in December 2016.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available